---
figid: PMC2921766__nihms202026f8
figtitle: Dopamine D2 Receptor Signaling Modulates Mutant Ataxin-1 S776 Phosphorylation
  and Aggregation
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC2921766
filename: nihms202026f8.jpg
figlink: /pmc/articles/PMC2921766/figure/F8/
number: F8
caption: 'D2R/S100B Signaling Pathway: D2R agonist or BRC activate G-protein-coupled
  inhibitory receptor, D2R, causing Gi proteins to bind and inhibit adenylate cyclase
  cAMP production, lowering PKA activity and decreasing S776 phosphorylation of PKA
  substrate ataxin-1, reducing inclusion bodies and neurodegeneration. FSK or other
  adenylate cyclase activator increases cAMP production and PKA activity, increasing
  S776 phosphorylation of PKA substrate ataxin-1, producing inclusion bodies and increasing
  neurodegeneration. H89 inhibits PKA S776 phosphorylation of ataxin-1. BRC could
  be potentially therapeutic by reducing mutant ataxin-1 S776 phosphorylation and
  reducing SCA1 neurodegeneration.'
papertitle: Dopamine D2 Receptor Signaling Modulates Mutant Ataxin-1 S776 Phosphorylation
  and Aggregation.
reftext: SM Hearst, et al. J Neurochem. ;114(3):706-716.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9500099
figid_alias: PMC2921766__F8
figtype: Figure
redirect_from: /figures/PMC2921766__F8
ndex: dbd88347-dee8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2921766__nihms202026f8.html
  '@type': Dataset
  description: 'D2R/S100B Signaling Pathway: D2R agonist or BRC activate G-protein-coupled
    inhibitory receptor, D2R, causing Gi proteins to bind and inhibit adenylate cyclase
    cAMP production, lowering PKA activity and decreasing S776 phosphorylation of
    PKA substrate ataxin-1, reducing inclusion bodies and neurodegeneration. FSK or
    other adenylate cyclase activator increases cAMP production and PKA activity,
    increasing S776 phosphorylation of PKA substrate ataxin-1, producing inclusion
    bodies and increasing neurodegeneration. H89 inhibits PKA S776 phosphorylation
    of ataxin-1. BRC could be potentially therapeutic by reducing mutant ataxin-1
    S776 phosphorylation and reducing SCA1 neurodegeneration.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - brc
  - brn
  - br
  - Dop2R
  - Dop1R2
  - ATPsynbeta
  - Atpalpha
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
---
